CN102000233A - Oral traditional Chinese medicine for knife wounds - Google Patents

Oral traditional Chinese medicine for knife wounds Download PDF

Info

Publication number
CN102000233A
CN102000233A CN2010105318648A CN201010531864A CN102000233A CN 102000233 A CN102000233 A CN 102000233A CN 2010105318648 A CN2010105318648 A CN 2010105318648A CN 201010531864 A CN201010531864 A CN 201010531864A CN 102000233 A CN102000233 A CN 102000233A
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
radix
treatment
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105318648A
Other languages
Chinese (zh)
Inventor
王钊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105318648A priority Critical patent/CN102000233A/en
Publication of CN102000233A publication Critical patent/CN102000233A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an oral traditional Chinese medicine preparation for fractures, traumatic injury, various knife wounds and internal lesions caused by overexertion. The oral traditional Chinese medicine powder is prepared from frankincense, myrrh, safflower, rhubarb, himalayan teasel root, draconis sanguis, pyrite, ground beetle, angelica, drynaria baronii and carbonized hair. The oral traditional Chinese medicine is a natural medicine, has obvious effects on promoting blood circulation to stop pain, removing blood stasis, restoring menstrual flow, promoting reunion of fractured bones, promoting wound healing, promoting tissue regeneration and the like, and is mainly used for treating fractures, traumatic injury, various knife wounds, internal lesions caused by overexertion and the like. The traditional Chinese medicine does not have special smell, and is suitable for both adults and children; the traditional Chinese medicine has high curative effect, has obvious effect on alleviating pain, and can take effect after being taken for 40 minutes at the soonest, and the patient does not feel painful or can feel relieved pain; the traditional Chinese medicine has a course of treatment, with 30 days for a course of treatment, common patients can recover within one course of treatment, and serious patients can recover within 2-3 courses of treatment; and the treatment statistics on patients with fractures, traumatic injury and various internal lesions caused by overexertion indicate that the effective rate is up to 100%, the curative ratio is up to 98%, and the traditional Chinese medicine does not have any toxic or side effect.

Description

The red injury oral Chinese medicine
Technical field
The present invention relates to a kind of fracture, traumatic injury patient uses medicine, especially for the oral Chinese medicine preparation of fracture, traumatic injury, various red injury, impairment caused by overstrain.
Background technology
In the bone injury field, adopting traditional method usually is operative treatment, folder steel plate, to fracture dislocation forced resetting, fixes with Gypsum Fibrosum and gauze at present, and it is slow knitting often to occur, and causes fracture to close on joint osteoporosis decalcification, produces adverse consequences.The traditional Chinese medical science on fractures, with union of fracture be divided into early, in, back three periods, in treatment, be the Therapeutic Principle in three periods with blood circulation promoting and blood stasis dispelling, reunion of bone, liver and kidney tonifying respectively; But the traditional Chinese medical science particularly has limitation at serious intra-articular fracture and the extremity fracture of treatment aspect the fracture of ligament, blood vessel, nerve injury, the course of treatment is long, and curative effect is undesirable, the side effect in addition that has.
Summary of the invention
The object of the invention provide a kind of short treating period, curative effect height, nontoxic, have no side effect the red injury oral Chinese medicine of treatment fracture, traumatic injury, various red injury, impairment caused by overstrain.
Amount of drug of the present invention be the inventor according to secret prescription handed down in the family from generation to generation, draw through groping for many years to put into practice simultaneously, each amounts of components is for all having better curative effect in the following weight parts scope.This Chinese medicine is to be made by following Chinese medicine raw materials by weight proportion:
Olibanum 15~30g, Myrrha 15~30g, Flos Carthami 20~40g, Radix Et Rhizoma Rhei 10~25g, Radix Dipsaci 15~30g, Sanguis Draxonis 15~30g, Pyritum 20~35g, eupolyphage sece steleophaga 15~30, drynaria baronii 30~45g, Radix Angelicae Sinensis 30~50g, Crinis Carbonisatus 10~20g;
The carbide that described Crinis Carbonisatus becomes for the between twenty and fifty hair color roasting of not having hair dyed;
Each component of above-mentioned dosage is crushed to 60~80 orders makes powder or other dosage form.
Chinese medicine of the present invention selects for use following materials of weight proportions component to make:
Olibanum 25~30g, Myrrha 25~30, Flos Carthami 30~40g, Radix Et Rhizoma Rhei 20~25g, Radix Dipsaci 25~30g, Sanguis Draxonis 25~30g, Pyritum 25~35g, eupolyphage sece steleophaga 25~30g, drynaria baronii 30~45g, Radix Angelicae Sinensis 35~45g, Crinis Carbonisatus 15~20g.
Preferred ingredients dosage of the present invention is:
Olibanum 30g, Myrrha 30g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 30g, Sanguis Draxonis 30g, Pyritum 35g, eupolyphage sece steleophaga 30g, drynaria baronii 45g, Radix Angelicae Sinensis 50g, Crinis Carbonisatus 20g.
Olibanum in the said components: all pains of blood stasis trusted subordinate, the arthralgia pain clonic spasm of the muscle, ulcer sore pain, traumatic injury, skin infection festers; Radix Angelicae Sinensis: enrich blood, promoting the circulation of blood, the merit that nourishes blood; Drynaria baronii: the kidney invigorating analgesia, blood circulation-invigorating tendon-strengthening, invigorating the liver and kidney, reuniting the fractured tendons and bones, promoting blood circulation and stopping pain; Myrrha: ulcer sore pain, trusted subordinate, all pains of muscles and bones, traumatic blood stasis, but external expelling pus and promoting granulation; Radix Et Rhizoma Rhei: purging heat and dredging bowels, the clots absorbing removing mass, yellow cellulitis, edema, blood stasis gathers, the external application detumescence of relieving inflammation or internal heat, carbuncle sore tumefacting virus; Radix Dipsaci, Flos Carthami: promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving; The Radix Dipsaci invigorating the liver and kidney, reuniting the fractured tendons and bones, invigorate blood circulation, promoting the circulation of blood detumescence, granulation promoting pain relieving, strong waist knee joint; Pyritum: the blood and relieving pain that looses promotes union of fracture, reunion of fractured tendons and bones; Eupolyphage sece steleophaga: have effects such as relaxing muscles and tendons to promote blood circulation, blood stasis removing stimulate the menstrual flow, reducing swelling and alleviating pain; Crinis Carbonisatus: contain carbon element, cystine and lipid, various trace elements such as calcic, sodium, potassium, copper, ferrum, manganese in the ash can shorten and clotting time and blood plasma recalcification time.The present invention invigorates blood circulation to enrich blood, granulation promoting reunion of fractured tendons and bones medicine, promotes union of fracture, all pains of blood stasis trusted subordinate, the arthralgia pain clonic spasm of the muscle is auxilliary, major-minor phase and, make each component drug effect produce synergism.
The present invention compared with prior art has following advantage: 1, the used medicine of the present invention is a pure natural medical, has promoting blood circulation and stopping pain, and blood stasis removing stimulates the menstrual flow, reunion of fractured tendons and bones, and remarkable efficacy such as expelling pus and promoting granulation cure mainly diseases such as fracture, traumatic injury, various red injury, impairment caused by overstrain; 2, this Chinese medicine does not have special odor, is fit to adult, child administration; 2, curative effect height, relieving pain is especially taken the soonest and was promptly started effect in 40 minutes, and obviously sensation is not bitterly or pain relief; Short treating period, with 30 days be a course of treatment, generally in one, serious symptom is 2~3 courses of treatment; According to the nearly 3 years use treatment statistics to 173 various impairment caused by overstrain patients such as example fracture, traumatic injury, effective percentage reached 100%, and cure rate reaches 98%, and without any side effects, takes the no vomiting and diarrhoea phenomenon in back, and is harmless to liver, brain, the heart, kidney, do not have allergy and reacts.
[usage and dosage]: 1, obey 2~3 every day, each 3~5g, 30 days is a course of treatment; Taking medicine preceding is introduction with Chinese liquor, and the child is cut down according to the circumstance according to the age body weight.
[taboo] avoids pungent food and greasy food.
[specification] every packed 10g.
[storage] sealing.
The specific embodiment
Following examples are in order to further specifying the present invention, but not as limitation of the present invention.
Embodiment 1:
Be used for fracture prescription 1: Olibanum 30g, Myrrha 30g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 30g, Sanguis Draxonis 30g, Pyritum 35g, eupolyphage sece steleophaga 30g, drynaria baronii 45g, Radix Angelicae Sinensis 50g, Crinis Carbonisatus 20g.
Be used for fracture prescription 2: Olibanum 25g, Myrrha 25g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 25g, Sanguis Draxonis 30g, Pyritum 35g, eupolyphage sece steleophaga 25g, drynaria baronii 45g, Radix Angelicae Sinensis 40g, Crinis Carbonisatus 20g.
Embodiment 2:
Be used for the bruise prescription: Olibanum 25g, Myrrha 25g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 30g, Sanguis Draxonis 30g, Pyritum 30g, eupolyphage sece steleophaga 30g, drynaria baronii 35g, Radix Angelicae Sinensis 40g, Crinis Carbonisatus 10g.
Embodiment 3:
Be used for weak impairment caused by overstrain prescription: Olibanum 25g, Myrrha 25g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 25g, Sanguis Draxonis 30g, Pyritum 25g, eupolyphage sece steleophaga 30g, drynaria baronii 35g, Radix Angelicae Sinensis 50g, Crinis Carbonisatus 10g.
Clinical drug of the present invention is selected from example in year October 173 in March, 2006 to 2009, maximum 69 years old age, and minimal ages 8 years old, wherein one-sided limb fracture 42 examples, lumbar vertebra incarceration fracture 3 examples, calcaneus comminuted fracture 17 examples, the fracture of falling is hindered 5 examples; Merge bruise 65 examples, joint dislocation 13 examples, limbs open injury 28 examples.Classification of fracture is pressed the typing standard, the I type: the fissure fracture of phalanges distal joint face, no articular surface displacement; II type: refer to have tangible articular surface fracture displacement, but the fracture pulverizing is not serious; III type: the serious comminuted fracture of the heavy damage of articulations digitorum manus face and distal tibial.I type 33 examples in this case history 95 routine miscellaneous fractures, II type 26 examples, III type 36 examples.
Criterion of therapeutical effect: the healing evaluation to Pilon fracture is divided into: excellent, good, differ from 3 three grades.Excellent: healing fully, 75% ankle motion recovers, normal gait; Very: pain is arranged during walking, but do not hinder one's work and light activity, 50% ankle motion recovers, normal gait; Difference: suffer from limb pain, hinder one's work and walk.The ankle joint motions are less than 50%, and swelling is obvious, and there is the medial and lateral malleolus displacement in visible ankle deformity.
This treatment is taken medicine the oral medicine instructions of taking in observing by all kinds of fracture and bruise: obeys every day three times, and each 3g, 30 days is a course of treatment, is introduction with Chinese liquor when taking medicine.
Retain information 121 example statistics therapeutic outcomes according to following up a case by regular visits to feedback: in 121 examples, effective 121 examples, invalid 0 example, effective percentage 100%; Cure 119 examples, cure rate 98.35%.
Employing clinical comparison statistics, fracture and bruise are used oral medicine 50 examples of the present invention (31 examples of fracturing, bruise 19 examples) and are contrasted with SHENYANG HONGYAO, and statistics shows as a result, uses the effect significant difference in red medicine treatment situation of the present invention and contrast and the complication.
Two groups of curative effect of medication are used comparing result
Figure BSA00000332525500041

Claims (3)

1. red injury oral Chinese medicine is characterized in that this Chinese medicine is to be made by following Chinese medicine raw materials by weight proportion:
Olibanum 15~30g Myrrha 15~30g
Flos Carthami 20~40g Radix Et Rhizoma Rhei 10~25g
Radix Dipsaci 15~30g Sanguis Draxonis 15~30g
Pyritum 20~35g eupolyphage sece steleophaga 15~30g
Drynaria baronii 30~45g Radix Angelicae Sinensis 30~50g
Crinis Carbonisatus 10~20g
The carbide that described Crinis Carbonisatus becomes for the between twenty and fifty hair color roasting of not having hair dyed;
Each component of above-mentioned dosage is crushed to 60~80 orders makes powder or other dosage form.
2. according to the described red injury oral Chinese medicine of claim 1, it is characterized in that this Chinese medicine made by following materials of weight proportions component:
Olibanum 25~30g Myrrha 25~30g
Flos Carthami 30~40g Radix Et Rhizoma Rhei 20~25g
Radix Dipsaci 25~30g Sanguis Draxonis 25~30g
Pyritum 25~35g eupolyphage sece steleophaga 25~30g
Drynaria baronii 30~45g Radix Angelicae Sinensis 35~45g
Crinis Carbonisatus 15~20g.
3. according to the described red injury oral Chinese medicine of claim 1, it is characterized in that this Chinese medicine made by following materials of weight proportions component:
Olibanum 30g Myrrha 30g
Flos Carthami 40g Radix Et Rhizoma Rhei 25g
Radix Dipsaci 30g Sanguis Draxonis 30g
Pyritum 35g eupolyphage sece steleophaga 30g
Drynaria baronii 45g Radix Angelicae Sinensis 50g
Crinis Carbonisatus 20g.
CN2010105318648A 2010-10-25 2010-10-25 Oral traditional Chinese medicine for knife wounds Pending CN102000233A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105318648A CN102000233A (en) 2010-10-25 2010-10-25 Oral traditional Chinese medicine for knife wounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105318648A CN102000233A (en) 2010-10-25 2010-10-25 Oral traditional Chinese medicine for knife wounds

Publications (1)

Publication Number Publication Date
CN102000233A true CN102000233A (en) 2011-04-06

Family

ID=43808102

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105318648A Pending CN102000233A (en) 2010-10-25 2010-10-25 Oral traditional Chinese medicine for knife wounds

Country Status (1)

Country Link
CN (1) CN102000233A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102793893A (en) * 2012-08-27 2012-11-28 刘伟娟 Preparation method for traditional Chinese medicine lotion for treatment of liver depression fire formation-type closed fracture
CN104435571A (en) * 2014-11-18 2015-03-25 王献美 Tendon-relaxing and bone-strengthening capsule
CN105434752A (en) * 2015-12-25 2016-03-30 陈新宇 Fracture healing promoting medicinal composition and preparation thereof
CN105770615A (en) * 2014-12-22 2016-07-20 天津嘉创生物科技有限公司 Traditional Chinese medicine suspension for treating rear-quarter palsy of dog and preparation method thereof
CN107007762A (en) * 2017-06-16 2017-08-04 郜金元 A kind of Chinese medicine composition, its preparation method and application for treating fracture
CN111297997A (en) * 2020-01-16 2020-06-19 钱茂发 Oral Chinese medicinal composition for treating bone diseases and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102793893A (en) * 2012-08-27 2012-11-28 刘伟娟 Preparation method for traditional Chinese medicine lotion for treatment of liver depression fire formation-type closed fracture
CN104435571A (en) * 2014-11-18 2015-03-25 王献美 Tendon-relaxing and bone-strengthening capsule
CN105770615A (en) * 2014-12-22 2016-07-20 天津嘉创生物科技有限公司 Traditional Chinese medicine suspension for treating rear-quarter palsy of dog and preparation method thereof
CN105434752A (en) * 2015-12-25 2016-03-30 陈新宇 Fracture healing promoting medicinal composition and preparation thereof
CN107007762A (en) * 2017-06-16 2017-08-04 郜金元 A kind of Chinese medicine composition, its preparation method and application for treating fracture
CN111297997A (en) * 2020-01-16 2020-06-19 钱茂发 Oral Chinese medicinal composition for treating bone diseases and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102908442B (en) Composition for treating traumatic injuries and medicinal liquor thereof
CN102327380A (en) Chinese medicinal composition for treating knee osteoarthritis
CN102000233A (en) Oral traditional Chinese medicine for knife wounds
CN100394955C (en) Chinese traditional medicine preparation for treating bone fracture and traumatic injury
CN105560662A (en) External-use traditional Chinese medicine composition for treating knee osteoarthritis
CN101983710B (en) Medicine for external application in orthopedics, production method and application method thereof
CN105920570A (en) Quick-acting externally applied traditional Chinese medicine for treating rheumatoid bone diseases and preparation method
CN103169822B (en) Synovitis hui-nationality ointment and preparation method thereof
CN1733047A (en) Medicine for treating traumatic injury
CN102342983B (en) Chinese medicinal composition for treating pain in the legs and numbness of the extremities and preparation method of preparation thereof
CN106728615A (en) Chinese medicine composition for synthetism life bone and preparation method thereof
CN101703619A (en) Chinese medicament for treating hyperosteogeny and osteoarthritis
CN101496838A (en) Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof
CN103127353A (en) Pharmaceutical composition for treating rheumatoid arthritis
CN101194985B (en) Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny
CN104857463A (en) Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis
CN103191305A (en) Traditional Chinese medicine composition for treating hyperosteogeny
CN104027451B (en) A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica
CN102091204B (en) Traditional Chinese medicinal composition for treating traumatic injury and deep phlebitis, and preparation method and use thereof
CN1246022C (en) Fracture setting pellet
CN103432509B (en) The topical agent for the treatment of prolapse of lumbar intervertebral disc
CN102526365B (en) Bonesetting capsules for treating traumatic injury
CN101904922B (en) Plaster for treating pain caused by femoral head necrosis
CN106177775A (en) A kind of Chinese medicine composition treating hyperosteogeny
CN106474325A (en) A kind of Chinese medicine preparation for treating cervical spondylopathy and waist dish outstanding and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20110406